Proellex®

DRUG2 trials

Sponsors

Repros Therapeutics Inc.

Conditions

EndometriosisUterine Fibroids

Phase 2

Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

CompletedNCT00958334

Repros Therapeutics Inc.Uterine Fibroids

Start: 2006-09-07End: 2008-10-15Updated: 2019-06-18

Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study

TerminatedNCT00958412

Repros Therapeutics Inc.Endometriosis

Start: 2009-02-28End: 2009-08-31Updated: 2019-02-12